Literature DB >> 19115512

A review of human carcinogens--Part A: pharmaceuticals.

Yann Grosse, Robert Baan, Kurt Straif, Béatrice Secretan, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Laurent Galichet, Vincent Cogliano.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19115512     DOI: 10.1016/s1470-2045(08)70286-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  40 in total

1.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

2.  Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder.

Authors:  Takashi Yorifuji; Toshihide Tsuda; Philippe Grandjean
Journal:  J Natl Cancer Inst       Date:  2010-01-12       Impact factor: 13.506

3.  Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.

Authors: 
Journal:  Ophthalmology       Date:  2015-08-19       Impact factor: 12.079

4.  Biochemical and immunological characterization of annexin B30 from Clonorchis sinensis excretory/secretory products.

Authors:  Lei He; Mengyu Ren; Xueqing Chen; Xiaoyun Wang; Shan Li; Jinsi Lin; Chi Liang; Pei Liang; Yue Hu; Huali Lei; Meng Bian; Yan Huang; Zhongdao Wu; Xuerong Li; Xinbing Yu
Journal:  Parasitol Res       Date:  2014-05-27       Impact factor: 2.289

5.  Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort.

Authors:  Agnès Fournier; Sylvie Mesrine; Laure Dossus; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Nathalie Chabbert-Buffet
Journal:  Breast Cancer Res Treat       Date:  2014-04-30       Impact factor: 4.872

Review 6.  Preventable exposures associated with human cancers.

Authors:  Vincent James Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Lauby-Secretan; Fatiha El Ghissassi; Véronique Bouvard; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Christopher P Wild
Journal:  J Natl Cancer Inst       Date:  2011-12-12       Impact factor: 13.506

7.  Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.

Authors:  Marie Stiborová; Katerina Levová; Frantisek Bárta; Zhanquan Shi; Eva Frei; Heinz H Schmeiser; Daniel W Nebert; David H Phillips; Volker M Arlt
Journal:  Toxicol Sci       Date:  2011-11-15       Impact factor: 4.849

8.  Mitochondrial relocation of a common synthetic antibiotic: A non-genotoxic approach to cancer therapy.

Authors:  Kyoung Sunwoo; Miae Won; Kyung-Phil Ko; Miri Choi; Jonathan F Arambula; Sung-Gil Chi; Jonathan L Sessler; Peter Verwilst; Jong Seung Kim
Journal:  Chem       Date:  2020-03-25       Impact factor: 22.804

9.  Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.

Authors:  Truc Nguyen; Pamela M Vacek; Patrick O'Neill; Richard B Colletti; Barry A Finette
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

10.  Women and heart disease: neglected directions for future research.

Authors:  Elizabeth Barrett-Connor
Journal:  J Cardiovasc Transl Res       Date:  2009-07-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.